US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

 
• By Sue Sutter
  
Hearing
The FDA is holding a listening session on several aspects of the adcomm process. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers